5.46
전일 마감가:
$5.54
열려 있는:
$5.54
하루 거래량:
455.08K
Relative Volume:
0.68
시가총액:
$438.82M
수익:
$14.02M
순이익/손실:
$-84.03M
주가수익비율:
-3.7143
EPS:
-1.47
순현금흐름:
$-125.54M
1주 성능:
+7.06%
1개월 성능:
-24.69%
6개월 성능:
-13.06%
1년 성능:
+10.98%
Meiragtx Holdings Plc Stock (MGTX) Company Profile
명칭
Meiragtx Holdings Plc
전화
646-860-7985
주소
450 EAST 29TH STREET, NEW YORK, NY
MGTX을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
MGTX
Meiragtx Holdings Plc
|
5.46 | 409.86M | 14.02M | -84.03M | -125.54M | -1.47 |
![]()
ONC
Beone Medicines Ltd Adr
|
258.27 | 26.01B | 3.81B | -644.79M | -669.77M | -6.24 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
445.85 | 114.30B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
AKTX
Akari Therapeutics Plc Adr
|
1.3499 | 41.83M | 0 | 0 | 0 | 0.00 |
![]()
VRNA
Verona Pharma Plc Adr
|
83.98 | 6.29B | 0 | -153.72M | -103.81M | -2.00 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
484.93 | 63.90B | 14.09B | 4.50B | 2.96B | 39.28 |
Meiragtx Holdings Plc Stock (MGTX) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2024-07-31 | 재개 | Chardan Capital Markets | Buy |
2020-10-23 | 개시 | RBC Capital Mkts | Outperform |
2020-09-15 | 재개 | BofA Securities | Buy |
2019-09-03 | 개시 | Piper Jaffray | Overweight |
2019-02-27 | 재확인 | Chardan Capital Markets | Buy |
2018-07-03 | 개시 | Barclays | Overweight |
2018-07-03 | 개시 | BofA/Merrill | Buy |
모두보기
Meiragtx Holdings Plc 주식(MGTX)의 최신 뉴스
ProShare Advisors LLC Purchases 4,910 Shares of MeiraGTx Holdings plc (NASDAQ:MGTX) - Defense World
MeiraGTx Holdings plc (NASDAQ:MGTX) Holdings Lifted by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. - Defense World
Deutsche Bank AG Buys 13,111 Shares of MeiraGTx Holdings plc (NASDAQ:MGTX) - Defense World
Some Confidence Is Lacking In MeiraGTx Holdings plc (NASDAQ:MGTX) As Shares Slide 25% - simplywall.st
(MGTX) Technical Data - news.stocktradersdaily.com
Northern Trust Corp Boosts Holdings in MeiraGTx Holdings plc (NASDAQ:MGTX) - Defense World
MeiraGTx Holdings plc (NASDAQ:MGTX) Shares Purchased by D. E. Shaw & Co. Inc. - Defense World
Prosight Management, LP Reduces Stake in MeiraGTx Holdings PLC - GuruFocus
Coave Therapeutics Establishes New Scientific Advisory Board to Accelerate Innovation in Genetic Medicines for Eye and CNS Diseases - GlobeNewswire Inc.
FY2025 EPS Estimates for MeiraGTx Cut by Chardan Capital - Defense World
Price T Rowe Associates Inc. MD Grows Stock Holdings in MeiraGTx Holdings plc (NASDAQ:MGTX) - Defense World
How to Take Advantage of moves in (MGTX) - news.stocktradersdaily.com
Tower Research Capital LLC TRC Buys 2,016 Shares of MeiraGTx Holdings plc (NASDAQ:MGTX) - Defense World
Chardan Capital Lowers MeiraGTx (NASDAQ:MGTX) Price Target to $35.00 - Defense World
MeiraGTx Holdings plc (NASDAQ:MGTX) Shares Sold by Voya Investment Management LLC - Defense World
Dimensional Fund Advisors LP Has $2.43 Million Stock Position in MeiraGTx Holdings plc (NASDAQ:MGTX) - Defense World
MeiraGTx Announces the Presentation of Four Posters at the Ameri - GuruFocus
Chardan Adjusts MeiraGTx Price Target to $35 From $38, Maintains Buy Rating - marketscreener.com
MGTX: Chardan Capital Lowers Price Target but Maintains Buy Rati - GuruFocus
MGTX: Chardan Capital Lowers Price Target but Maintains Buy Rating | MGTX Stock News - GuruFocus
MeiraGTx (MGTX) Reports Strong Q1 Revenue Growth and Advances Cl - GuruFocus
MeiraGTx Announces the Presentation of Four Posters at the American Society of Gene and Cell Therapy (ASGCT) 2025 Annual Meeting - The Manila Times
MeiraGTx Holdings PLC Q1 2025 Earnings: EPS Misses at -$0.51, Re - GuruFocus
MeiraGTx Holdings to Present Four Poster Sessions at ASGCT 2025 Annual Meeting - Nasdaq
Dated alert on MeiraGTx collaboration with Hologen AI withdrawn - marketscreener.com
MeiraGTx Reports First Quarter 2025 Financial and Operational Results - ADVFN
MeiraGTx Holdings PLC (MGTX) Reports Q1 Loss, Misses Revenue Estimates - Yahoo Finance
MeiraGTx Holdings plc SEC 10-Q Report - TradingView
MeiraGTx Holdings plc Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
Wells Fargo & Company MN Has $144,000 Stock Position in MeiraGTx Holdings plc (NASDAQ:MGTX) - Defense World
MeiraGTx Granted FDA Regenerative Medicine Advanced Therapy (RMA - GuruFocus
MeiraGTx (MGTX) Gains RMAT Designation for Parkinson's Treatment - GuruFocus
FDA grants RMAT status to MeiraGTx’s Parkinson’s treatment By Investing.com - Investing.com South Africa
MeiraGTx (MGTX) Gains FDA RMAT Designation for Parkinson's Treat - GuruFocus
MeiraGTx gets FDA RMAT status for its Parkinson’s disease treatment - Seeking Alpha
MeiraGTx (MGTX) Gains FDA RMAT Designation for Parkinson's Treatment | MGTX Stock News - GuruFocus
MeiraGTx Holdings Receives FDA RMAT Designation for AAV-GAD - TipRanks
MeiraGTx Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for AAV-GAD for the Treatment of Parkinson's Disease - The Manila Times
FDA grants RMAT status to MeiraGTx’s Parkinson’s treatment - Investing.com
MeiraGTx Holdings Receives RMAT Designation from FDA for AAV-GAD Gene Therapy in Parkinson's Disease - Nasdaq
Invesco Ltd. Increases Stake in MeiraGTx Holdings plc (NASDAQ:MGTX) - Defense World
MeiraGTx Holdings PLC expected to post a loss of 49 cents a shareEarnings Preview - TradingView
MeiraGTx Holdings plc's (NASDAQ:MGTX) Shift From Loss To Profit - simplywall.st
MeiraGTx Holdings plc (NASDAQ:MGTX) Shares Bought by Geode Capital Management LLC - Defense World
Kadmon Announces Sale of 1.4 Million Shares of MeiraGTx Holdings plc - ACCESS Newswire
What is the investor’s view on MeiraGTx Holdings plc (MGTX)? - uspostnews.com
MeiraGTx Holdings plc (NASDAQ:MGTX) Shares Sold by JPMorgan Chase & Co. - Defense World
MeiraGTx Reports Fourth Quarter and Full Year 2024 Financial and Operational Results and Recent Business Updates - ADVFN
MeiraGTx CFO Richard Giroux sells $144,000 in stock By Investing.com - Investing.com India
MeiraGTx CFO Richard Giroux sells $144,000 in stock - Investing.com
Russell Investments Group Ltd. Has $1.72 Million Stake in MeiraGTx Holdings plc (NASDAQ:MGTX) - Defense World
Meiragtx Holdings Plc (MGTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):